Wow, game-changing #SELECT data out at #HeartFailure2024 !

Sema 2.4mg ⬇️ CVd+HF events by 21% in HF subgroup of n=4,286

Remarkably, efficacy & safety consistent in both HFrEF & HFpEF

Supports health status gains in #STEPHFpEF & likely to have regulatory/guideline implications

#ACM & #DCM
Genotype matters‼️ The underlying genotype plays a crucial role in assessing the risks associated w/ exercise and determining the appropriate management

Exercise risks vary among different genotypes
#PKP2 !
#DSP LMNA & TMEM43

For individuals with #DCM , exercise restrictions may not be necessary unless specific risk factors are present, but personalized risk assessment is crucial

Me: Dear 🫀universe, I would like a state of the art paper to contextualize new aficamten data from #HFA2024 in HCM

Journal of Cardiac Failure: I got you 😉💜

👇🏽👇🏽👇🏽HFSA ColumbiaCardiology

A huge thank you to Sameed Khatana, MD MPH 🩺for a fantastic Penn Cardiology #GrandRounds presentation this morning on socioeconomic & environmental determinants of #cardiovascularhealth 🫀

#MedEd #Cardiology

#ACC75 Fact of the Day: Do you know the name of ACC's first female president (1982-1983) whose legacy remains in her focus on health care delivery, payment methods and government relations?

If you guessed Suzanne B. Knoebel, MD, MACC -- you're right!

#ACCAdvocacy #ACCPresident

Quick trip up to Boston on my CCU rotation day off to attend #HRS2024 and present an interesting case of dynamic ECG patterns of LVH/LV strain in a HCM patient who started, discontinued and then restarted mavacamten.
Nosheen Reza, MD Anjali Owens

Claim your spot in the Genomic and Precision Medicine Early Career competition at #AHA24 in Chicago, Nov. 16-18
Submit your science by June 6, then apply!
To learn more, visit bit.ly/3pSegR6
#AHA100years
AHA Science AHA Council on Genomic and Precision Medicine

Attending #HRS2024 ? Don't miss sessions led by our all-star 💫 physicians!

Find a session ➡️ spr.ly/6016dwrTE

🚨 Penn Cardiology folks 🚨
Be sure to tag us in your posts this weekend!

#HeartRhythm #Cardiology

Check out the May Issue of JCF!
Absolute 🔥 content to inform clinical care

Journal of Cardiac Failure is your home for great science combined with impactful perspective pieces to advance discourse in the field

onlinejcf.com/current

#HFBeat Episode Drop 🎧 Michael H. Beasley, MD and Priya Umapathi welcome @nurtitionHF and Adrian da Silva to discuss the evaluation and management of obesity in patients with heart failure. Plus, Michael talks to transplant recipient Mr. Spiro Papakosmas about his experience with heart

🔥ICYMI: This thoughtful Patient Focus article by Spencer Carter & Jenny Thibodeau, MD, MSCS summarizes when patients admitted for ADHF should think about palliative & hospice care.

The authors break down research data & translate it into patient decision-making.

🔗 bit.ly/4dAK7u5

Surveillance with Dual Non-invasive Testing for Acute Cellular Rejection After Heart Transplantation: Outcomes from the SHORE Registry - JHLT

jhltonline.org/article/S1053-…

Kiran Khush Jeff Teuteberg Shelley Hall Palak Shah #VanBakel Nir Uriel, MD MSc Ashwin R MUSC-CardiologyFellowshipPrograms

#HeartFailure2024 was a reminder of this tremendous development over just 4 years (and during a pandemic).

We randomized the first patient in REDWOOD-HCM Cohorts 1-2 in January 2020. Since then, we randomized the first patient in Cohort 3, Cohort 4, FOREST-HCM, SEQUOIA-HCM,

Registration is open for the biggest event of the year! 🤩

The HFSA Annual Scientific Meeting is bringing the best of heart failure education, science, research, practical management, and networking opportunities to Atlanta, GA.

Don't wait! Secure your discounted rate for

Senthil Selvaraj Senthil Selvaraj, MD, MS, MA from Duke University discusses his recent JAMA study on the V142I transthyretin variant among Black individuals and how it may affect cardiovascular health.

Listen to the full podcast: ja.ma/3UWKbwO

An honor to guest edit CardiologyClinics and highlight work by excellent colleagues such as Andrew Higgins Ann Gage Zachary Il'Giovine Carlos L. Alviar MD, FACC Elliott Miller venu menon Willard Applefeld MD Paul Cremer MD Ryan Keane Sanjeeb Bhattacharya Nosheen Reza, MD David M. Dudzinski MD JD Eduardo Mireles-Cabodevila Ian Persits, DO, MS

The third presentation is by Greg Lewis focusing on the exercise response in #SEQUOIA #HCM
#HeartFailure2024 #CardioTwitter

The second presentation is by Dr. Caroline Coats focusing on the dosing and safety of aficamten in #SEQUOIA #HCM trial

#HeartFailure2024 #CardioTwitter

The #SEQUOIA #HCM trial results are here - Placebo-controlled trial of #aficamten in #obstructive #HCM

3 presentations in 3 threads - follow along

This is the first presentation by Martin Maron, MD sharing the primary results
Follow along #CardioTwitter #HeartFailure2024